Corrigendum to “Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study” [Eur J Cancer 196 (2024) 113424] (European Journal of Cancer (2024) 196, (S0959804923007268), (10.1016/j.ejca.2023.113424))

Pien Debets; Koen M. A. Dreijerink; Anton F. Engelsman; Max Dahele; Harm R. Haak; Rebecca V. Steenaard; Ellen Kapiteijn; Eleonora Corssmit; C. Willemien Menke-van der Houven van Oordt

doi:10.1016/j.ejca.2024.115123

Corrigendum to “Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study” [Eur J Cancer 196 (2024) 113424] (European Journal of Cancer (2024) 196, (S0959804923007268), (10.1016/j.ejca.2023.113424))

Pien Debets
, Koen M. A. Dreijerink
, Anton F. Engelsman
, Max Dahele
, Harm R. Haak
, Rebecca V. Steenaard
, Ellen Kapiteijn
, Eleonora Corssmit
, C. Willemien Menke-van der Houven van Oordt^*

^*Corresponding author for this work

Amsterdam UMC - Vrije Universiteit Amsterdam
Amsterdam UMC
Maxima Medical Centre
Maastricht University
Netherlands Comprehensive Cancer Organization (IKNL)
Leiden University

Research output: Contribution to journal › Comment/Letter to the editor › Academic

13 Downloads (Pure)

Abstract

The authors regret to inform that we need to make a small correction regarding the number of patients with a hormone producing tumor in our recent publication. This change does not regard any of the primary outcomes of the study but we believe should be updated nonetheless. The corrected numbers of patients with a hormone producing tumor are detailed below (Tables 1 and 2). The authors would like to apologise for any inconvenience caused.

Original language	English
Article number	115123
Journal	European Journal of Cancer
Volume	213
Early online date	2024
DOIs	https://doi.org/10.1016/j.ejca.2024.115123
Publication status	Published - Dec 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.ejca.2024.115123

Corrigendum-to-impact-of-edp-m-on-survival-of-patients-with-metastatic-adrenocortical-carcinoma.pdfFinal published version, 290 KBLicence: Taverne

Fingerprint

Dive into the research topics of 'Corrigendum to “Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study” [Eur J Cancer 196 (2024) 113424] (European Journal of Cancer (2024) 196, (S0959804923007268), (10.1016/j.ejca.2023.113424))'. Together they form a unique fingerprint.

Cite this

Debets, P., Dreijerink, K. M. A., Engelsman, A. F., Dahele, M., Haak, H. R., Steenaard, R. V., Kapiteijn, E., Corssmit, E., & Willemien Menke-van der Houven van Oordt, C. (2024). Corrigendum to “Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study” [Eur J Cancer 196 (2024) 113424] (European Journal of Cancer (2024) 196, (S0959804923007268), (10.1016/j.ejca.2023.113424)). European Journal of Cancer, 213, Article 115123. https://doi.org/10.1016/j.ejca.2024.115123

Debets, Pien ; Dreijerink, Koen M. A. ; Engelsman, Anton F. et al. / Corrigendum to “Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma : A population-based study” [Eur J Cancer 196 (2024) 113424] (European Journal of Cancer (2024) 196, (S0959804923007268), (10.1016/j.ejca.2023.113424)). In: European Journal of Cancer. 2024 ; Vol. 213.

@article{ea8d577bd674439daad21bb5deb2b0dd,

title = "Corrigendum to “Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study” [Eur J Cancer 196 (2024) 113424] (European Journal of Cancer (2024) 196, (S0959804923007268), (10.1016/j.ejca.2023.113424))",

abstract = "The authors regret to inform that we need to make a small correction regarding the number of patients with a hormone producing tumor in our recent publication. This change does not regard any of the primary outcomes of the study but we believe should be updated nonetheless. The corrected numbers of patients with a hormone producing tumor are detailed below (Tables 1 and 2). The authors would like to apologise for any inconvenience caused.",

author = "Pien Debets and Dreijerink, \{Koen M. A.\} and Engelsman, \{Anton F.\} and Max Dahele and Haak, \{Harm R.\} and Steenaard, \{Rebecca V.\} and Ellen Kapiteijn and Eleonora Corssmit and \{Willemien Menke-van der Houven van Oordt\}, C.",

note = "Publisher Copyright: {\textcopyright} 2024 The Authors",

year = "2024",

month = dec,

doi = "10.1016/j.ejca.2024.115123",

language = "English",

volume = "213",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Pergamon",

}

Debets, P, Dreijerink, KMA , Engelsman, AF , Dahele, M, Haak, HR, Steenaard, RV, Kapiteijn, E, Corssmit, E & Willemien Menke-van der Houven van Oordt, C 2024, 'Corrigendum to “Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study” [Eur J Cancer 196 (2024) 113424] (European Journal of Cancer (2024) 196, (S0959804923007268), (10.1016/j.ejca.2023.113424))', European Journal of Cancer, vol. 213, 115123. https://doi.org/10.1016/j.ejca.2024.115123

Corrigendum to “Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study” [Eur J Cancer 196 (2024) 113424] (European Journal of Cancer (2024) 196, (S0959804923007268), (10.1016/j.ejca.2023.113424)). / Debets, Pien; Dreijerink, Koen M. A.; Engelsman, Anton F. et al.
In: European Journal of Cancer, Vol. 213, 115123, 12.2024.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Corrigendum to “Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma

T2 - A population-based study” [Eur J Cancer 196 (2024) 113424] (European Journal of Cancer (2024) 196, (S0959804923007268), (10.1016/j.ejca.2023.113424))

AU - Debets, Pien

AU - Dreijerink, Koen M. A.

AU - Engelsman, Anton F.

AU - Dahele, Max

AU - Haak, Harm R.

AU - Steenaard, Rebecca V.

AU - Kapiteijn, Ellen

AU - Corssmit, Eleonora

AU - Willemien Menke-van der Houven van Oordt, C.

PY - 2024/12

Y1 - 2024/12

N2 - The authors regret to inform that we need to make a small correction regarding the number of patients with a hormone producing tumor in our recent publication. This change does not regard any of the primary outcomes of the study but we believe should be updated nonetheless. The corrected numbers of patients with a hormone producing tumor are detailed below (Tables 1 and 2). The authors would like to apologise for any inconvenience caused.

AB - The authors regret to inform that we need to make a small correction regarding the number of patients with a hormone producing tumor in our recent publication. This change does not regard any of the primary outcomes of the study but we believe should be updated nonetheless. The corrected numbers of patients with a hormone producing tumor are detailed below (Tables 1 and 2). The authors would like to apologise for any inconvenience caused.

UR - https://www.scopus.com/pages/publications/85209247346

U2 - 10.1016/j.ejca.2024.115123

DO - 10.1016/j.ejca.2024.115123

M3 - Comment/Letter to the editor

C2 - 39550299

SN - 0959-8049

VL - 213

JO - European Journal of Cancer

JF - European Journal of Cancer

M1 - 115123

ER -

Debets P, Dreijerink KMA , Engelsman AF , Dahele M, Haak HR, Steenaard RV et al. Corrigendum to “Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study” [Eur J Cancer 196 (2024) 113424] (European Journal of Cancer (2024) 196, (S0959804923007268), (10.1016/j.ejca.2023.113424)). European Journal of Cancer. 2024 Dec;213:115123. Epub 2024. doi: 10.1016/j.ejca.2024.115123

Corrigendum to “Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study” [Eur J Cancer 196 (2024) 113424] (European Journal of Cancer (2024) 196, (S0959804923007268), (10.1016/j.ejca.2023.113424))

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this